Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Doxycycline Hyclate*(Doxycycline Hyclate)

Medicare prescription drug cost, prescriptions and prescribers, 2024

-

Medicare cost

Medicare drug plans spent on Doxycycline Hyclate* (doxycycline hyclate) in 2024, for prescriptions and refills.

Medicare cost

-

Prescriptions

-

- per claim

Patients

-

- prescribers

Total spending, 2024

$81.5M

$17.58 per patient

Questions and answers

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Doxycycline Hyclate* was $81.5M in 2024, after a high of $121.3M in 2022.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Tris Pharma Inc2,034,628$20.7M
West-Ward/HikmaHIK.L logoHIK.L1,244,758$15.2M
Epic Pharma LLC903,781$11.5M
Viona Pharmaceu933,801$10.6M
Sun PharmaceutiSUNPHARMA.NS logoSUNPHARMA.NS798,162$9.8M
Amneal PharmaceAMRX logoAMRX268,721$2.9M
Alembic Pharmac21,215$2.9M
Puracap Laborat313,976$2.8M
Mutual Pharm Co73,010$2.3M
Chartwell Rx Ll37,978$614K
Avet Pharmaceut4,845$521K
Jg Pharma, Inc.632$297K
Zydus PharmaceuZYDUSLIFE.NS logoZYDUSLIFE.NS1,040$252K
Solco Healthcar731$247K
Acella Pharmace17,704$205K
Teva USATEVA logoTEVA655$170K
Mayne Pharma In108$87K
Northstar Rx Ll279$72K
Ajanta Pharma LAJANTPHARM.NS logoAJANTPHARM.NS547$69K
Lupin PharmaceuLUPIN.NS logoLUPIN.NS256$51K
Actavis/TevaTEVA logoTEVA5,207$47K
Apotex Corp122$28K
Piramal Critica97$27K
Avpak658$22K
Major Pharmaceu2,415$21K
Larken Labs766$18K
Fosun Pharma Us86$14K
Mylan InstitutiVTRS logoVTRS73$13K
AHP301$3,428
Bi-Coastal Phar500$2,426

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube